Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Darlene Antoine

Lorraine University Faculty of Medicine, France

Title: Genomics of the obese patient before and after bariatric surgery

Biography

Biography: Darlene Antoine

Abstract

Obesity is today a worldwide clinical and public health burden. It is associated with an increased risk of type 2 diabetes, cardiovascular disease, cancer, metabolic syndrome, nonalcoholic steatohepatitis and mortality. The identification of multiple genetic defects responsible for monogenic syndromic and non-syndromic, oligogenic and polygenic forms of obesity over the last 20 years, confirms an inherited component. A partial genetic overlap has been demonstrated between BMI variation in general populations and extreme forms of obesity. However, little is known on the genetic determinants of BMI variation among obese people. For this study, clinical data were extracted from the CHRU Lorraine’s patient database. Blood was collected during the surgery for DNA extraction. The genotyping was performed using 240k SNPs Illumina BeadChip. Quality control was performed using GenomeStudio 2.0, PLINK considering a call rate >99%, and call Freq >95%. The results show that 169 (48%) of patients are carriers at least one of these mutations predisposing to obesity, and 182 are non-carriers, which explains that carriers for these mutations present 1.3 unit of BMI more than in the general population before the surgery. The variants do not have effect on weight loss in response to the modifications due to lifestyle and the surgery after two, seven, and 12 months. In summary, the results suggest that rare and low frequency genetic variants associated with BMI in a general population have six times more effect on BMI in the morbidly obese cohort. And different genetic variants control the response to obesity lifestyle modification and surgery.